Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Integrated longitudinal multiomics study identifies immune programs associated with acute COVID-19 severity and mortality

Journal of Clinical Investigation(2024)10.1172/jci176640Source: DataRank Database

Integrated longitudinal multiomics study identifies immune programs associated with acute COVID-19 severity and mortality is a research paper published in Journal of Clinical Investigation (2024). On theSindex it has a DataRank of 0.910. It has been cited 32 times, with 19 citing works in its 1-hop citation network.

N/A

0.910DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access32 citations · 19 citing works in its network

Download PDF

Cite:

Linked data & code

nct

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT04378777

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (40 grants)Impact (FWCI 16.46)OA: goldTopics (83)Linked Datasets (24)DataCite Reuse (24)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 58%Citation Network 42%

Base Score Contribution

0.524

From this paper's citation signal

Citation Network Contribution

0.386

From 11 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 19 citers.

Frontiers in plasma proteome profiling platforms: innovations and applications
Clinical Proteomics202425 citations21 referencesContributes 0.155
Aerosolized Dornase Alfa (DNase I) for the Treatment of Severe Respiratory Failure in COVID-19: A Randomized Controlled Trial
Open Forum Infectious Diseases202511 citations19 referencesContributes 0.131
Optimizing Clinical Management of COVID-19: A Predictive Model for Unvaccinated Patients Admitted to ICU
Pathogens20251 citations23 referencesContributes 0.030
Baseline Dysregulation in B, T, and NK Cells in COVID-19 Predicts Increased Late Mortality but Not Long-COVID Symptoms: Results from a Single-Center Observational Study
Viruses20253 citations50 referencesContributes 0.028
Identification of patient demographic, clinical, and SARS-CoV-2 genomic factors associated with severe COVID-19 using supervised machine learning: a retrospective multicenter study
BMC Infectious Diseases20252 citations44 referencesContributes 0.025

Authors (43)

Cole Maguire ORCID,Ravi K. Patel ORCID,Pramod Shinde ORCID,Anna Konstorum ORCID,Casey P. Shannon ORCID

Live enrichment

PubMed:38690733 PMC:PMC11060740 OpenAlex:https://openalex.org/W4396507749

National Institutes of Health

Grant: 5R01AI135803-03,5U19AI118608-04,5U19AI128910-04,4U19AI090023-11,4U19AI118610-06,R01AI145835-01A1S1,5U19AI062629-17,5U19AI057229-17,5U19AI125357-05,5U19AI128913-03,3U19AI077439-13,5U54AI142766-03,5R01AI104870-07,3U19AI089992-09,3U19AI128913-03,5T32DA018926

National Institute of Allergy and Infectious Diseases

Grant: 3U19AI1289130,U19AI128913-04S1,R01AI122220

National Science Foundation

Grant: DMS2310836

NIAID NIH HHS

Grant: U19 AI167903

NIDA NIH HHS

Grant: T32 DA018926

NIAID NIH HHS

Grant: U19 AI118608

NIAAA NIH HHS

Grant: K08 AA027837

NIAID NIH HHS

Grant: R01 AI122220

NIAID NIH HHS

Grant: R01 AI135803

NIAID NIH HHS

Grant: U19 AI090023

NIAID NIH HHS

Grant: U19 AI118610

NIAID NIH HHS

Grant: U54 AI142766

NIAID NIH HHS

Grant: R01 AI104870

NIAID NIH HHS

Grant: R01 AI145835

NIAID NIH HHS

Grant: U19 AI062629

NIAID NIH HHS

Grant: U19 AI125357

NIAID NIH HHS

Grant: U19 AI128913

NIAID NIH HHS

Grant: R01 AI132774

NIAID NIH HHS

Grant: U19 AI089992

NIAID NIH HHS

Grant: U19 AI057229

NIAID NIH HHS

Grant: U19 AI077439

NIAID NIH HHS

Grant: U19 AI128910

NCATS NIH HHS

Grant: UL1 TR001863

National Institutes of Health

Grant: 5U19AI057229-17

Influenza responses and repertoire in vaccination, infection and tonsil organoids.

National Science Foundation

Grant: 2310836

Robust Classification and uncertainty quantification for non-iid samples

National Institutes of Health

Grant: 5R01AI122220-04

Genomics of NFκB-mediated gene regulation in multiple sclerosis

National Institutes of Health

Grant: 5U19AI125357-05

Dysfunction of Innate Immunity in Asthma

National Institutes of Health

Grant: 5U19AI118608-04

Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity

National Institutes of Health

Grant: 5T32DA018926-18

Pre-Doctoral Training in Interdisciplinary Neuroscience

National Institutes of Health

Grant: 4U19AI118610-06

Dengue Human Immunology Project Consortium (DHIPC)

National Institutes of Health

Grant: 5U19AI077439-10

IL-13 and IL-17 dynamics in the asthmatic airway

National Institutes of Health

Grant: 5U19AI128910-04

Integrative Omics of HepB Vaccine Response in Co-Infection with Parasites

National Institutes of Health

Grant: 5R01AI135803-03

FUNGAL PATHOGENESIS OF MODERATE TO SEVERE ASTHMA

National Institutes of Health

Grant: 5U19AI128913-03

Mapping Immune Responses to CMV in Renal Transplant Recipients

National Institutes of Health

Grant: 4U19AI090023-11

System Biological Analyses of Innate and Adaptive Responses to Vaccination

National Institutes of Health

Grant: 5R01AI145835-04

Long Term Immunity Following Yellow Fever Vaccination

National Institutes of Health

Grant: 5U19AI089992-08

Systems Immune Profiling of Divergent Responses to Infection

National Institutes of Health

Grant: 5U19AI062629-17

Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax

National Institutes of Health

Grant: 5R01AI104870-07

Distinct contributions of CCR4 versus CCR7 to thymocyte localization and central tolerance

National Institutes of Health

Grant: 5U54AI142766-03

A 3D Tissue Map of the Human Lymphatic System

FWCI

16.46

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttp://www.jci.org/articles/view/176640/files/pdf

publisherhttp://www.jci.org/articles/view/176640/files/pdf

publisherhttps://www.jci.org/articles/view/176640/files/pdf

journalhttps://doi.org/10.1172/jci176640

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38690733

Fields of Study

COVID-19 epidemiological studiesCOVID-19 Clinical Research StudiesCOVID-19 and Mental Health0303 health sciences03 medical and health sciences

MeSH Terms

COVID-19SARS-CoV-2MultiomicsAdultAgedFemaleHumansLongitudinal StudiesMaleMiddle AgedSeverity of Illness IndexCytokines

Keywords

Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineImmune systemPandemicImmunologyVirologyIntensive care medicineInternal medicineDiseaseInfectious disease (medical specialty)Outbreakinnate immunityadaptive immunityCovid-19MaleCoronaviruses11 Medical and Health Sciences (for)Medical and Health SciencesLung (rcdc)Severity of Illness IndexClinical Research (rcdc)31 Biological sciences (for-2020)2.1 Biological and endogenous factorsLongitudinal Studies32 Biomedical and Clinical Sciences (for-2020)Male (mesh)LungHumans (mesh)3 Good Health and Well Being (sdg)COVID-19 (mesh)Middle AgedBiological sciencesInfectious DiseasesSeverity of Illness Index (mesh)Multiomics (mesh)CytokinesFemaleImmunology (science-metrix)AdultIMPACC Network610Emerging Infectious Diseases (rcdc)Clinical Research42 Health sciences (for-2020)Middle Aged (mesh)GeneticsHumans3204 Immunology (for-2020)AgedBiomedical and Clinical SciencesGenetics (rcdc)Aged (mesh)Health sciencesCoronaviruses (rcdc)2.1 Biological and endogenous factors (hrcs-rac)MultiomicsLongitudinal Studies (mesh)Emerging Infectious DiseasesGood Health and Well BeingCytokines (mesh)Infectious Diseases (rcdc)Female (mesh)Adult (mesh)Clinical Medicine

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 11 of Frontiers in plasma proteome profiling platforms: innovations and applications

10.6084/m9.figshare.26737374.v1figshare

Additional file 9 of Frontiers in plasma proteome profiling platforms: innovations and applications

10.6084/m9.figshare.26737368.v1figshare

Additional file 6 of Frontiers in plasma proteome profiling platforms: innovations and applications

10.6084/m9.figshare.26737359figshare

Additional file 3 of Frontiers in plasma proteome profiling platforms: innovations and applications

10.6084/m9.figshare.26737350.v1figshare

Additional file 12 of Frontiers in plasma proteome profiling platforms: innovations and applications

10.6084/m9.figshare.26737377figshare

Additional file 11 of Frontiers in plasma proteome profiling platforms: innovations and applications

10.6084/m9.figshare.26737374figshare

Additional file 9 of Frontiers in plasma proteome profiling platforms: innovations and applications

10.6084/m9.figshare.26737368figshare

Additional file 7 of Frontiers in plasma proteome profiling platforms: innovations and applications

10.6084/m9.figshare.26737362figshare

Additional file 4 of Frontiers in plasma proteome profiling platforms: innovations and applications

10.6084/m9.figshare.26737353.v1figshare

Additional file 5 of Frontiers in plasma proteome profiling platforms: innovations and applications

10.6084/m9.figshare.26737356figshare

Additional file 7 of Frontiers in plasma proteome profiling platforms: innovations and applications

10.6084/m9.figshare.26737362.v1figshare

Additional file 6 of Frontiers in plasma proteome profiling platforms: innovations and applications

10.6084/m9.figshare.26737359.v1figshare

Additional file 1 of Frontiers in plasma proteome profiling platforms: innovations and applications

10.6084/m9.figshare.26737344figshare

Additional file 8 of Frontiers in plasma proteome profiling platforms: innovations and applications

10.6084/m9.figshare.26737365.v1figshare

Additional file 5 of Frontiers in plasma proteome profiling platforms: innovations and applications

10.6084/m9.figshare.26737356.v1figshare

Additional file 1 of Frontiers in plasma proteome profiling platforms: innovations and applications

10.6084/m9.figshare.26737344.v1figshare

Additional file 4 of Frontiers in plasma proteome profiling platforms: innovations and applications

10.6084/m9.figshare.26737353figshare

Additional file 12 of Frontiers in plasma proteome profiling platforms: innovations and applications

10.6084/m9.figshare.26737377.v1figshare

Additional file 10 of Frontiers in plasma proteome profiling platforms: innovations and applications

10.6084/m9.figshare.26737371.v1figshare

Additional file 8 of Frontiers in plasma proteome profiling platforms: innovations and applications

10.6084/m9.figshare.26737365figshare

Related Papers (10)

CeDR Atlas: a knowledgebase of cellular drug response

Top 16%

1.3DataRank

Nucleic Acids Research(2021)

co-cited

10.1093/nar/gkab897

Can we predict the severe course of COVID-19 - a systematic review and meta-analysis of indicators of clinical outcome?

PLoS ONE(2021)

co-cited

10.1371/journal.pone.0255154

The role of neutrophil extracellular traps in acute lung injury

Frontiers in Immunology(2022)

co-cited

10.3389/fimmu.2022.953195

Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s disease

Cell Reports Medicine(2022)

co-cited

10.1016/j.xcrm.2022.100661

Longitudinally monitored immune biomarkers predict the timing of COVID-19 outcomes

PLoS Computational Biology(2022)

co-cited

10.1371/journal.pcbi.1009778

Mis-spliced transcripts generate de novo proteins in TDP-43–related ALS/FTD

Science Translational Medicine(2024)

co-cited

10.1126/scitranslmed.adg7162

scDrug: From single-cell RNA-seq to drug response prediction

N/A

1.3DataRank · unranked

Computational and Structural Biotechnology Journal(2023)

co-cited

10.1016/j.csbj.2022.11.055

Artificial intelligence for proteomics and biomarker discovery

N/A

0.895DataRank · unranked

Cell Systems(2021)

co-cited

10.1016/j.cels.2021.06.006

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

N/A

1.6DataRank · unranked

The Lancet(2020)

co-cited

10.1016/s0140-6736(20)30183-5

The Perseus computational platform for comprehensive analysis of (prote)omics data

Top 2%

9.1DataRank

Nature Methods(2016)

co-cited

10.1038/nmeth.3901

Integrated longitudinal multiomics study identifies immune programs associated with acute COVID-19 severity and mortality

FAIR Checklist

DataRank Breakdown

Top 5 citers driving the network score

Authors (43)

Funding (40 grants)

Impact

Open Access

Topics

Linked Datasets (24)

Annotations (Europe PMC)

Related Papers (10)